Display options
Share it on

Int J Spine Surg. 2016 Apr 18;10:12. doi: 10.14444/3012. eCollection 2016.

Preliminary Results of Bioactive Amniotic Suspension with Allograft for Achieving One and Two-Level Lumbar Interbody Fusion.

International journal of spine surgery

Pierce D Nunley, Eubulus J Kerr, Philip A Utter, David A Cavanaugh, Kelly A Frank, Devan Moody, Brian McManus, Marcus B Stone

Affiliations

  1. Spine Institute of Louisiana, Shreveport, Louisiana, USA.

PMID: 27162714 PMCID: PMC4852597 DOI: 10.14444/3012

Abstract

BACKGROUND: Bone graft material for lumbar fusion was historically autologous bone graft (ABG). In recent years alternatives such as allograft, demineralized bone matrix (DBM), ceramics, and bone morphogenetic protein (BMP) have gained favor, although the complications of these are not fully understood. Bioactive amniotic suspension (BAS) with allograft is a new class of material derived from human amniotic tissue.

METHODS: Eligible patients receiving a one or two level lumbar interbody fusion with Nucel, a BAS with allograft, were contacted and scheduled for a mininmim 12 month follow-up visit. Patients were evaluated for fusion using CT's and plain radiographs. Clincal outcomes, including ODI, VAS back and leg were collected, as well as comorbidities including BMI, smoking status, diabetes and previous lumbar surgery.

RESULTS: One-level patients (N=38) were 71.1% female with mean age of 58.4 ± 12.7 and mean BMI of 30.6 ± 6.08. Two-level patients (N=34) were 58.8% female with mean age of 49.3 ±10.9 and mean BMI of 30.1 ± 5.82. Kinematic fusion was achieved in 97.4% of one-level patients and 100% of two-level patients. Baseline comorbidities were present in 89.5% of one-level patients and 88.2% of two-level patients. No adverse events related to BAS were reported in this study.

CONCLUSION: Fusion status is evaluated with many different biologics and varying methods in the literature. BAS with allograft in this study demonstrated high fusion rates with no complications within a largely comorbid population. Although a small population, BAS with allograft results were encouraging for one and two-level lumbar interbody fusion in this study. Further prospective studies should be conducted to investigate safety and efficacy in a larger population.

Keywords: Bone graft; Nucel; allograft; bioactive amniotic suspension; bone graft alternative; lumbar fusion

References

  1. Spine (Phila Pa 1976). 2006 Mar 1;31(5):542-7 - PubMed
  2. Spine J. 2010 Apr;10(4):313-20 - PubMed
  3. J Spinal Disord. 1999 Oct;12(5):380-5 - PubMed
  4. Spine J. 2008 Jul-Aug;8(4):570-7 - PubMed
  5. Injury. 2011 Sep;42 Suppl 2:S3-15 - PubMed
  6. Spine (Phila Pa 1976). 2013 May 20;38(12 ):E738-47 - PubMed
  7. Neurosurg Focus. 2001 Apr 15;10(4):E1 - PubMed
  8. J Orthop Surg Res. 2013 Dec 28;8:49 - PubMed
  9. ScientificWorldJournal. 2012;2012:263637 - PubMed
  10. J Neurosurg Spine. 2014 Dec;21(6):851-60 - PubMed
  11. J Spinal Disord. 1999 Apr;12(2):107-14 - PubMed
  12. Eur Spine J. 2015 Apr;24 Suppl 3:369-71 - PubMed
  13. Neurosurgery. 2008 May;62(5 Suppl 2):ONS423-31; discussion ONS431 - PubMed
  14. Spine (Phila Pa 1976). 2003 May 15;28(10 ):997-1001 - PubMed
  15. J Knee Surg. 2016 Aug;29(6):443-50 - PubMed
  16. J Surg Res. 2005 Dec;129(2):283-7 - PubMed
  17. Spine (Phila Pa 1976). 2006 Oct 15;31(22):2534-9; discussion 2540 - PubMed
  18. Blood. 2003 Aug 15;102(4):1548-9 - PubMed
  19. Spine (Phila Pa 1976). 2001 Dec 1;26(23):2623-8 - PubMed
  20. Spine (Phila Pa 1976). 2014 Feb 1;39(3):185-91 - PubMed
  21. Ann Intern Med. 2013 Jun 18;158(12):877-89 - PubMed
  22. Eur Spine J. 2016 Dec;25(12 ):3979-3989 - PubMed
  23. Eur Spine J. 2015 May;24(5):1066-73 - PubMed
  24. J Bone Joint Surg Am. 2013 Sep 4;95(17):1546-53 - PubMed
  25. J Surg Res. 2009 Apr;152(2):281-7 - PubMed
  26. J Spinal Disord Tech. 2002 Oct;15(5):337-49 - PubMed
  27. Spine (Phila Pa 1976). 2003 Jan 15;28(2):134-9 - PubMed
  28. Spine (Phila Pa 1976). 2002 Nov 1;27(21):2396-408 - PubMed
  29. Neurosurg Focus. 2002 Dec 15;13(6):e1 - PubMed
  30. J Neurosurg Spine. 2015 Jul;23(1):86-93 - PubMed
  31. Methods Enzymol. 2006;419:426-38 - PubMed
  32. Ann Intern Med. 2013 Jun 18;158(12):890-902 - PubMed
  33. Spine (Phila Pa 1976). 2012 Sep 15;37(20):E1264-72 - PubMed
  34. Spine (Phila Pa 1976). 2010 Sep 15;35(20):E1058-63 - PubMed
  35. Spine J. 2008 Nov-Dec;8(6):968-74 - PubMed
  36. Eur Spine J. 2008 Jun;17(6):822-5 - PubMed
  37. Acta Orthop Scand. 1978 Jun;49(3):269-77 - PubMed
  38. Lancet. 1980 May 31;1(8179):1156-8 - PubMed
  39. J Neurosurg Spine. 2015 Apr;22(4):358-66 - PubMed
  40. Tissue Eng Part A. 2012 Dec;18(23-24):2518-27 - PubMed
  41. Eur Spine J. 2013 May;22(5):1173-82 - PubMed
  42. Spine (Phila Pa 1976). 2001 Feb 1;26(3):320-34 - PubMed
  43. Bull Hosp Jt Dis (2013). 2013;71(1):39-48 - PubMed
  44. Spine (Phila Pa 1976). 1995 May 1;20(9):1055-60 - PubMed
  45. Int J Spine Surg. 2015 Feb 03;9:null - PubMed
  46. Eur Spine J. 2009 Apr;18(4):449-64 - PubMed
  47. Spine (Phila Pa 1976). 1993 Jun 15;18(8):983-91 - PubMed
  48. Clin Neurol Neurosurg. 2013 Jul;115(7):991-4 - PubMed

Publication Types